Monthly promotions and special prices on compounding products from MEDISCA.
Monthly promotions and special prices on compounding products from MEDISCA.
Monthly promotions and special prices on compounding products from MEDISCA.

Are you currently compounding with any hazardous active pharmaceutical ingredients such as apomorphone, azathioprin, cyclophosphamide, cyclosporine, diethylstilbestrol, estradiol, fluorouracil, medroxyprogesterone, phenytoin, progesterone, spironolactone, or tacrolimus?


If so, you must be compliant with General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings, which was formally published February 1, 2016 in the First Supplement to USP 39-NF 34. In an effort to provide an adequate timeframe to implement USP <800>, the chapter has a delayed official implementation date of July 1, 20181. While a two-year window may seem to provide sufficient time for preparation, it is important to note that this implementation date is when entities must be compliant; waiting too long to begin the process could negatively impact your practice.


Explore hazardous chemicals, devices and equipment for use with hazardous compounding, and find answers to frequently asked questions about USP <800> and hazardous compounding.

Hazardous Chemicals

View a list of the drugs supplied by MEDISCA that are currently on the NIOSH list of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, like testosterone, progesterone, among others.



LEARN MORE


Equipment & Devices for Hazardous Compounding

Special precautions must be taken when handling hazardous chemicals. Learn more about the equipment and devices that can help prevent or minimize your exposure. Our products include personal protective equipment, closed system transfer devices, emergency equipment, deactivation agents, and more.



LEARN MORE


Hazardous Drug Compounding FAQ (Frequently Asked Questions)

What is hazardous compounding? Who needs to comply with USP <800>? What kind of equipment do I need to use with hazardous chemicals? Find in our FAQ section answers to common questions about being compliant with USP <800> and how it will impact your compounding pharmacy practice.



LEARN MORE

1On September 29th, 2017 USP released a notification of intent to revise the official implementation date of USP General Chapter <800> to December 1, 2019.


GO BACK




Copyright® 1986-2017 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified MEDISCA is a proud VAWD-accredited facility